News and Events
Updated March 9, 2020
April 2020: Dr. DeFlilippis is named interim chief of the UofL Division of Cardiovascular MedicineMarch 2020: Dr. DeFilippis is interviewed about a new myocardial infarction study
November 2019: Dr. DeFilippis and colleagues publish invited Circulation White Paper "Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury"
July 2019: Dr. DeFilippis and collaborators receive University of Louisville ExCITE (Expediting Commercialization, Innovation, Translation, and Entrepreneurship) Program (an NIH Research Evaluation and Commercialization Hub) grant – "Point-of-Care Blood Assay Using Differential Calorimetry to Diagnose Acute Myocardial Infarction"
June 2019: Dr. DeFilippis and collaborators publish Circulation Research Viewpoint – "Myocardial Infarction as a Clinical End Point in Research: What Are We Really Talking About?"
June 2019: Dr. DeFilippis and collaborators receive a Jewish Heritage Fund for Excellence pilot grant - "Identification and classification of acute myocardial infarction using metabolites"
April 2019: James R. Ryan pledges an investment of $500,000 to the DeFilippis laboratory, establishing the James Ryan Fund for Cardiovascular Biomarker Research - "Gift to UofL aids research into biomarkers for cardiovascular disease" - UofL | Lane Report
December 2018 – The University of Louisville Foundation receives donation from Ionis Pharmaceuticals, Inc. to support research being conducted in conjunction with the Multi-Ethnic Study of Atherosclerosis (MESA)
June 2018: Dr. DeFilippis and Patrick Trainor publish an editorial in Annals of Internal Medicine, stressing the need for more accurate heart disease risk prediction models – "When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores"
February 2016: Lab receives Heart to Heart Grant from the Alpha Phi Foundation – "DeFilippis receives grant to test biomarker that may predict heart disease in women"
August 2013: Dr. DeFilippis becomes Principal Investigator of Project 5 of NIH Center for Excellence in Diabetes and Obesity Research grant – "Metabolomic Analysis of Atherothrombosis"
June 2013: Lab receives grant from AstraZeneca – "The Impact of Ticagrelor on In-Vivo Measures of Platelet Activation in Diabetics During Acute Atherothrombotic MI"